Beat the intellectual heat and invigorate yourself with a Delightful Evening tour of Chandigarh after the intense sessions and thought provoking discussions during QbD in Pharma Development World Congress. SELECTBIO cordially invites all conference participants to join us for Chandigarh by Evening Sightseeing Tour on April 17, 2015 in Chandigarh Tourism Open-Roof Double-Decker Tourist Coach. This trip will begin at 05:30 pm and will take about 2 and half hours.
The trip will include visit to Rose Garden, Capitol Complex, Sukhna Lake, Garden of Silence and Terrace Garden.
Don’t Forget to Carry Your Cams !!!
Many of you wonderful scientists must be having one or more of the following questions in your mind.
What is different in this QbD conference?
I have attended so many QbD conferences, why one more??
QbD is same always, what is new in this conference???
I am from XYZ department, will I gain anything????
I am busy, how should I take out time for this conference?????
However, we wish to tell you that our “QbD in Pharma Developement World Congress 2015 ” is going to be a great conference. We have done efforts to make this conference the best possible with several happenings which have never been collectively there before at any QbD conference viz Problem Solving Software Training and discussion on the following and many more topics.
- Question based Review and Continued Process Verification
- Question based Approach to Product Development
- Integration of Quality by Design from Product Development to API Production
- Methods to Minimize the Impact of Uncertainty in Pharma Quality Attributes
- Realization of Quality by Design in ANDA Submissions
- How to Demonstrate the Relevant Diligence on Filing
- Risk Based Approach for Efficient Development of the DS Control Strategy
- QbD & QbR to Reduce Health Care Cost while Maintaining Quality
- How to find the Robust Setpoint for Design Space Combining DOE Models, Monte Carlo Simulations and Design Space Concept
- ATP and CQA For Analytical Methods
- Risk Assessment In Aqbd and Design Space for Analytical Methods
- Tools that Play a Critical Role in Implementation of Qbd for Biotech Processes
- Five-D Concept of QbD
- Live Demonstration on How to Utilize Tools of Qbd i.e. DoE & PAT
- Industry Case-Studies Related to Implementation of PAT
- How To Implement DoE & PAT Systematically & Effectively during Development & Manufacturing of Solid Oral/Liquid Orals/ Semisolids & Parenteral Dosage Forms
- DoE for Development of a Modified-Release Tablet
- Advanced DoE for Improved Process Understanding
- Statistics in Product Development – Beyond DoE
- Use of other Statistical Tools to Build Robust Products & Processes
- Chemometric Tools in QbD -Chemometric Methods & their Advantages and Principle
- QbD Based Systematic Development of Nanoemulsions for Natural Product
- Analytical Quality By Design (Aqbd) Approach In RP-HPLC Method Development
- Quality By Design (QbD) Approach in Formulation of Oral Delayed Release Tablet of LansoprazolFor details, please find attached the agenda of the conference. Looking into the above topics being covered, we feel that we have the answers to the above questions
- You were looking for the best QbD scientists and there they are.
- This is not like the earlier conferences since the quality of talks is exceptionally high and specifically meant to enhance your process and product understanding.
- QbD has to be implemented holistically and if you are a scientist from Quality assurance, Analytical development, API Development or Formulation Development, it is relevant for you.
- You are entrusted with responsibility to develop products and processes of high quality for effective ANDA filings and that exactly the aim of this conference is.
- You spend lot of time in sorting out QbD data related problems which your colleagues must be facing. Be there, get your data problems solved and save time.
- Finally get tips on how to develop medicine in cost effective manner and give your company a return which is much higher than investment in this conference.
So what are you waiting for? Register now
Our worthy Speakers and we all will be doing our best and Now it is your presence which will make it an Awesome Conference.!!!
Looking forward to see you in Chandigarh.
How Question Based Development can Demonstrate Quality by Design and how it can Facilitate Continued Process Verification??
Recent organizational changes at CDER/FDA have created a new ‘supper’ Office of Pharmaceutical Quality to improve information and knowledge sharing and decision- making; (a) within New and Generic CMC Review function, and (b) between CMC Review and CGMP Compliance functions. ‘Question based Review’ and ‘Continued Process Verification’ are two themes can be expected to have a significant impact over the next several years on how product development, validation and manufacturing is carried out in industry and how FDA will review and inspect these functions.
If the above issue is important for you and you would like to be enlightened on the same you ought to be in Chandiarh for “QbD in Pharma Development World Congress 2015” on April 16, 2015 in Chandigarh. Dr Ajaz Hussain, Former FDA Reviewer and Currently Executive Director, NIPTE, USA will be there to address this issue and many more.
Just SMS QbD at 7696125050 and we will get back to you with more details.
Obsessed with QbD – Learn 20 Astonishing Tools from World Leaders at QbD in Pharma Development World Congress on April 16-18, 2015 in Chandigarh, India.
The conference i.e. QbD in Pharma Development World Congress, will have an exclusive one day Software Training/Workshop. on April 18, 2015. A series of workshops will be conducted by experts from different software developing organizations. The experts will impart hands-on training on different aspects of the commercially available software for implementation of QbD principles in Pharmaceutical & Biotech Industry.
All registered conference delegates can attend this workshop and no additional fee is required for attending the same. However, Pre-Registration is necessary. Seats will be reserved (For Workshop) on First-Come-First-Served basis. The registered participants will be provided software before hand and would need to carry their laptops in the workshop for hands-on training.
- Selection of goals, factors, responses
- Type of model and design
- Choosing and adapting a design
- Set specifications for a Design Space
- Screening to Optimizing factors
- Identifying Operating Regions that assure Good Quality Product.
- Robustness Testing & its Verification
- Full factorial DOE & Gage RR Study
- Interpreting the Analysis Report
- Visualizing the results
- Variable scaling, geometrical interpretation, and model evaluation
- Utilizing Multivariate Data Analysis (MVDA), Principal Component Analysis
- Partial Least Squares (PLS) for relating predictors and response
- Model diagnostics and validation of a PLS and OPLS model
- Batch Modeling using historical Production Batches
- Real time Problem solving
- Desirability, Combining responses & Specifying a mixture problem
- Data examples from Pharma, Biopharma industry
- Case Studies: Development to Manufacture, API Synthesis, Formulation Design
- Monitoring Design Space at Production Level
Assay Miniaturization Strategies: Smaller and Cheaper Cell-Based Assays for HCA
Learn from Dr Anthony Davies, Director, TCIQ, Queensland, Australia at CellTech India 2015 in Bangalore on March 2-3, 2015.
To sustain the viability of large-scale research programs running in academia and industry (especially when considering the current global economic climate), it is essential to reduce research costs wherever possible. With the advent of micron resolution robotics and nano-litre capable liquid handlers, assay miniaturization for large-scale High-Content Screening is now possible. The advantages of miniaturization are clear, when one considers the savings in reagents and experimental materials and experimental turnaround times. However miniaturization can also be costly to set up and difficult to deploy.
The Implementation of 3D Cell based Assays and High Content Imaging in Translational Research: Choosing the right tools for the Job
High Content Screening and analysis (HCS/A) technologies have over the last 15 years become widely adopted in both the academic and industrial research sectors. The acceptance of these technologies has in the large part been due to their demonstrable utility as both drug-discovery and basic research tools, indeed these imaging technologies such as HCS/A have the capability of providing researchers with a ready means of performing both large scale primary screens as well as permitting more detailed downstream analysis. Alongside the rapid uptake of these technologies, we have also seen a concomitant increase in the demand for more refined and flexible hardware and biologically relevant cell based assay approaches that can be utilized for translational research. Currently one of the biggest drivers in the field is the need to improve the physiological relevance of cell based assays used within translational research campaigns. To achieve these aims many are turning their attention to the use of primary cells and/or 3 dimensional cellular assay models. In summary this presentation will cover the key technological and methodological approaches we are currently implementing within our High Content Analysis workflows to meet our translational research goals. This talk will be presented at CellTech India 2015 in Bangalore on March 2, 2015 by Dr. Anthony Mitchell Davies, Queensland, Australia. Dr. Anthony Mitchell Davies is currently the Center Director: Translational Cell Imaging, Institute of Health Biomedical Innovation, Australia
Advanced Cell Based Assay and Phenotype Screening Approaches in Biomedical Research and Drug Discovery – One Day Training Course with Live Demo
With the ever-increasing demand for improved productivity in research through the generation of robust analysis outputs has driven both the development and deployment of phenotypic cell-based approaches to drug discovery. In contrast to the more traditional cellular analysis and target-based approaches, here the researcher is able to evaluate the efficacy of potential therapeutics by monitoring the physiological state of cells through the simultaneous analysis of multiple cellular parameters in the context of an intact biological system. This course will cover the key features of the latest imaging technologies and the best approaches to using these technologies for phenotypic cell-based screening. As part of this course we will also cover the some of the latest approaches to 3D cell culture, lab on a chip and the analytical and methodological challenges these new methods represent to the researcher. This course will cover
- An appraisal of the key technologies currently being utilized in this area of research
- Presentation of research data from a few selected studies using both 2d functional and 3D assay technologies
- Hands on demo showing demonstrating advanced analysis techniques
- Q & A and Group Discussion
Lab Visit & Live Demo
A Lab visit and Live Demo has been arranged for the course participants at advanced high content and high throughput screening facility of C-CAMP. The visit will include a live demo of both the high end platforms.